Exploration Capital, LLC

Exploration Capital, LLC discloses dealings in Fresh Tracks Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 20 December 2023 to 10 June 2024, the count stands at 42 filings.

Purchases make up the whole of the open-market record (42 purchases, €923k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2024 alone, the filings show 41 purchases and no sales.

In size, the median ticket on the buying side is €5,255. 3 out of 42 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 11 June 2024, the filings show an open-market purchase worth €75k in Fresh Tracks Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.